title: [The team medical support in out-patient chemotherapy: a role of nurses].
abstract: The number of cancer patients and families desiring home-based care and out-patient chemotherapy has been increasing. Hence, a support system for home-based care is urgently needed for a patient with recurrent and/or advanced unresectable cancer who recieved cancer chemotherapy. The cancer therapy especially in patients with colorectal cancer could have expected an improvement of the prognosis utilizing FOLFOX/FOLFIRI, a standard therapy established in Europe and America. Thereby, it was well recognized that the department of out-patient chemotherapy is very important for continuous venous infusion using a central venous port. Since May 2005, we started an out-patient department for patients receiving cancer chemotherapy and a risk management in order to establish a patient care team. The important thing we should recognize about the out-patient treatment is that there are many cases of cancer patients who are in the state of poor nourishment caused by plural factors such as protein-calorie malnutrition (PCM) by an intake disturbance, and the poor absorption in glucose, protein and fat which are necessary for a good metabolism. The poor nutritional status causes a deterioration of immune function and complications such as infectious diseases. Thereby, a good management of nourishment to the patient who received cancer chemotherapy is an important supportive therapy. It appears that a good management of nourishment prevented and/or alleviated the complication that caused by the treatment of cancer chemotherapy. Because of the out-patient treatment is to treat a patient in a short period of time without thorough evaluation about the same for in hospitalized patient, a team medical support, a prudent policy of chemotherapy by the medical team members consisting of nurses, pharmacists, dietitian, chemotherapist and the self-care guidance of the patient are strongly required.
authors.affiliation: Dept. of Nurse, Shiga Prefectual Hospital.
authors.forename: Naomi
authors.initials: N
authors.lastname: Doi
authors.forename: Tadashi
authors.initials: T
authors.lastname: Shigematsu
authors.forename: Keiko
authors.initials: K
authors.lastname: Amamori
authors.forename: Toshimi
authors.initials: T
authors.lastname: Yamada
authors.forename: Naoko
authors.initials: N
authors.lastname: Hattori
authors.forename: Setsuko
authors.initials: S
authors.lastname: Morisaki
authors.forename: Ayumi
authors.initials: A
authors.lastname: Matsuo
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Hatai
authors.forename: Ikuko
authors.initials: I
authors.lastname: Senba
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Shirai
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D044342:Malnutrition / Q000139:chemically induced / Q000628:therapy; D009369:Neoplasms / Q000188:drug therapy / Q000451:nursing*; D010045:Outpatients; D010348:Patient Care Team; D018570:Risk Assessment
chemical_list: D000970:Antineoplastic Agents